OLN · Olin Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $6.78B | $6.54B | $6.83B | $9.38B | $8.91B | $5.76B |
| Cost of Revenue | $6.28B | $5.80B | $5.67B | $7.19B | $6.62B | $5.37B |
| Gross Profit | $501.50M | $737.50M | $1.17B | $2.18B | $2.29B | $383.40M |
| R&D | - | - | - | - | - | - |
| SG&A | $463.30M | $408.50M | $406.70M | $393.90M | $416.90M | $422.00M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $521.60M | $518.10M | $533.40M | $598.80M | $582.50M | $568.40M |
| Operating Income | $5.30M | $296.50M | $712.10M | $1.78B | $1.85B | ($746.70M) |
| Interest Expense | $188.30M | $184.50M | $181.10M | $143.90M | $348.00M | $292.70M |
| Income Tax | ($60.00M) | $36.70M | $107.30M | $349.10M | $242.00M | ($50.10M) |
| Net Income | ($101.10M) | $105.00M | $452.00M | $1.33B | $1.30B | ($969.90M) |
| EPS - Basic | ($0.88) | $0.92 | $3.66 | $9.16 | $8.15 | ($6.14) |
| EPS - Diluted | ($0.88) | $0.91 | $3.57 | $8.94 | $7.96 | ($6.14) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $167.60M | $175.60M | $170.30M | $194.00M | $180.50M | $189.70M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | $784.50M | $823.50M | $858.80M | $941.90M | $868.30M | $674.70M |
| Accounts Payable | $806.10M | $861.60M | $775.40M | $837.70M | $847.70M | $729.20M |
| Current Assets | $1.97B | $2.08B | $1.97B | $2.16B | $2.25B | $1.72B |
| Total Assets | $7.33B | $7.58B | $7.71B | $8.04B | $8.52B | $8.27B |
| Current Liabilities | $1.63B | $1.63B | $1.53B | $1.56B | $1.68B | $1.20B |
| Long-term Debt | $2.72B | $2.71B | $2.59B | $2.57B | $2.58B | $3.84B |
| Total Liabilities | $5.46B | $5.52B | $5.44B | $5.50B | $5.87B | $6.82B |
| Stockholders' Equity | $1.84B | $2.02B | $2.23B | $2.54B | $2.65B | $1.45B |
| Retained Earnings | $2.14B | $2.36B | $2.58B | $2.22B | $1.01B | ($155.10M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $474.20M | $503.20M | $974.30M | $1.92B | $1.74B | $418.40M |
| Investing Cash Flow | ($319.60M) | ($283.70M) | ($340.80M) | ($259.70M) | ($197.40M) | ($835.70M) |
| Financing Cash Flow | ($163.00M) | ($212.60M) | ($656.90M) | ($1.65B) | ($1.55B) | $385.60M |
| CapEx | $226.30M | $195.10M | $236.00M | $236.90M | $200.60M | $298.90M |
| Free Cash Flow | $247.90M | $308.10M | $738.30M | $1.69B | $1.54B | $119.50M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 7.4% | 11.3% | 17.1% | 23.3% | 25.7% | 6.7% |
| Operating margin | 0.1% | 4.5% | 10.4% | 19.0% | 20.8% | -13.0% |
| EBITDA margin | 7.8% | 12.5% | 18.2% | 25.4% | 27.3% | -3.1% |
| Net margin | -1.5% | 1.6% | 6.6% | 14.2% | 14.6% | -16.8% |
| Free cash flow margin | 3.7% | 4.7% | 10.8% | 18.0% | 17.3% | 2.1% |
| FCF / Net income | -2.45 | 2.93 | 1.63 | 1.27 | 1.19 | -0.12 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 6.8% | 6.2% | 6.0% | 4.2% | 4.7% | 7.3% |
| Effective tax rate | - | 25.9% | 19.2% | 20.8% | 15.7% | - |
| Return on assets | -1.4% | 1.4% | 5.9% | 16.5% | 15.2% | -11.7% |
| Return on equity | -5.5% | 5.2% | 20.2% | 52.2% | 48.9% | -66.9% |
| Return on invested capital | 0.1% | 4.6% | 11.9% | 27.5% | 29.8% | -11.2% |
| Liquidity | ||||||
| Current ratio | 1.21 | 1.27 | 1.29 | 1.38 | 1.34 | 1.43 |
| Quick ratio | 0.73 | 0.77 | 0.73 | 0.78 | 0.82 | 0.87 |
| Cash ratio | 0.10 | 0.11 | 0.11 | 0.12 | 0.11 | 0.16 |
| Leverage | ||||||
| Debt / Equity | 1.48 | 1.34 | 1.16 | 1.01 | 0.97 | 2.65 |
| Debt / Assets | 0.37 | 0.36 | 0.34 | 0.32 | 0.30 | 0.46 |
| Debt / EBITDA | 5.16 | 3.33 | 2.08 | 1.08 | 1.06 | - |
| Interest coverage | 0.0x | 1.6x | 3.9x | 12.4x | 5.3x | -2.6x |
| Equity multiplier | 3.98 | 3.75 | 3.46 | 3.16 | 3.21 | 5.70 |
| Liabilities / Assets | 0.74 | 0.73 | 0.71 | 0.68 | 0.69 | 0.82 |
| Efficiency | ||||||
| Asset turnover | 0.93 | 0.86 | 0.89 | 1.17 | 1.05 | 0.70 |
| Inventory turnover | 8.00 | 7.05 | 6.60 | 7.64 | 7.62 | 7.97 |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | 46d | 52d | 55d | 48d | 48d | 46d |
| Days payable outstanding | 47d | 54d | 50d | 43d | 47d | 50d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | 37.1x | 15.1x | 5.9x | 7.2x | - |
| P / B | 1.3x | 2.0x | 3.1x | 3.1x | 3.5x | 2.7x |
| P / S | 0.4x | 0.6x | 1.0x | 0.8x | 1.1x | 0.7x |
| EV / EBITDA | 9.4x | 8.1x | 7.5x | 4.3x | 4.8x | - |
| Growth | ||||||
| Revenue growth (YoY) | 3.7% | -4.3% | -27.1% | 5.2% | 54.8% | -5.8% |
| Revenue CAGR (3y) | -10.2% | -9.8% | 5.9% | 15.3% | 8.7% | -2.8% |
| Revenue CAGR (5y) | 3.3% | 1.4% | -0.3% | 8.4% | 9.9% | 15.1% |
| Gross profit growth (YoY) | -32.0% | -36.7% | -46.6% | -4.9% | 498.4% | -42.8% |
| Operating income growth (YoY) | -98.2% | -58.4% | -60.0% | -3.9% | - | - |
| Net income growth (YoY) | - | -76.8% | -65.9% | 2.3% | - | -8483.2% |
| EPS growth (YoY) | - | -74.5% | -60.1% | 12.3% | - | -8671.4% |
| EPS CAGR (3y) | - | -51.5% | - | - | 59.8% | - |
| EPS CAGR (5y) | - | - | 12.9% | 22.4% | - | - |
| FCF growth (YoY) | -19.5% | -58.3% | -56.2% | 9.4% | 1189.0% | -48.4% |
| FCF CAGR (5y) | 15.7% | 5.9% | 7.2% | 36.6% | 36.5% | 6.8% |
| Book value growth (YoY) | -9.1% | -9.4% | -12.2% | -4.1% | 82.8% | -40.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$6.78B totalChlor Alkali Productsand Vinyls Segment$3.68B · 54.3%
Winchester Segment$1.72B · 25.4%
Epoxy Segment$1.37B · 20.2%
Product / service
$6.78B totalChlorinechlorinederivativesandothercoproducts$2.05B · 30.3%
Causticsoda$1.63B · 24.1%
Militaryandlawenforcement$1.09B · 16.0%
Epoxyresins$807.10M · 11.9%
Commercial$636.40M · 9.4%
Aromaticsandallylics$564.70M · 8.3%
Geographic
$3.68B totalUS$2.53B · 68.6%
Otherforeign$995.30M · 27.0%
Europe$160.00M · 4.3%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.35
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing OLIN Corp against the 5 most active filers in the same SIC group.
Dividends
$0.80/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| May 14, 2026 | $0.2000 |
| Mar 3, 2026 | $0.2000 |
| Nov 28, 2025 | $0.2000 |
| Aug 28, 2025 | $0.2000 |
| May 15, 2025 | $0.2000 |
| Mar 6, 2025 | $0.2000 |
| Nov 14, 2024 | $0.2000 |
| Aug 8, 2024 | $0.2000 |
| May 8, 2024 | $0.2000 |
| Mar 6, 2024 | $0.2000 |
| Nov 8, 2023 | $0.2000 |
| Aug 9, 2023 | $0.2000 |
| May 10, 2023 | $0.2000 |
| Mar 3, 2023 | $0.2000 |
| Nov 9, 2022 | $0.2000 |
| Aug 9, 2022 | $0.2000 |
| May 9, 2022 | $0.2000 |
| Mar 3, 2022 | $0.2000 |
| Nov 9, 2021 | $0.2000 |
| Aug 9, 2021 | $0.2000 |
| May 7, 2021 | $0.2000 |
| Mar 1, 2021 | $0.2000 |
| Nov 9, 2020 | $0.2000 |
| Aug 7, 2020 | $0.2000 |